BACKGROUND AND OBJECTIVES: Dyslipidemia confers a paradoxical survival advantage in patients with kidney failure. Data are limited in the earlier stages of chronic kidney disease (CKD). DESIGN, SETTING, PARTICIPANTS, AND MEASUREMENTS: This was a cohort study in 840 subjects with stage 3 to 4 CKD enrolled in the Modification of Diet in Renal Disease study. Cox models were used to examine the relationship of total cholesterol (TC), non-HDL-cholesterol (NHDL-C), triglycerides (TG), and HDL-cholesterol (HDL-C) with all-cause and cardiovascular disease (CVD) mortality and progression to kidney failure. RESULTS: During a mean follow-up of 10 years, there were 208 deaths, 128 deaths from CVD, and 554 subjects reached kidney failure. There was no association between tertiles of any of the lipid variables and mortality; the lowest HDL-C tertile (1.44, 1.18 to 1.78) had increased risk of kidney failure but covariate adjustment abolished this association. In analyses with lipids as continuous variables, there was a significant association with all-cause mortality for TC (hazard ratio [HR] per 10-mg/dl increase, 95% confidence intervals [CI] = 1.03, 1.0 to 1.06) that disappeared with covariate adjustment; there was no association of TG, HDL-C, and NHDL-C as continuous variables with all-cause or CVD mortality. There was a significant inverse association between HDL-C and kidney failure (HR = 0.93, CI = 0.87 to 0.99) in an unadjusted Cox model that was attenuated after adjustment for covariates (HR = 0.98 CI = 0.91 to 1.06). CONCLUSIONS: In this cohort, with predominantly nondiabetic CKD patients, hyperlipidemia is not an independent predictor of long-term outcomes.
BACKGROUND AND OBJECTIVES:Dyslipidemia confers a paradoxical survival advantage in patients with kidney failure. Data are limited in the earlier stages of chronic kidney disease (CKD). DESIGN, SETTING, PARTICIPANTS, AND MEASUREMENTS: This was a cohort study in 840 subjects with stage 3 to 4 CKD enrolled in the Modification of Diet in Renal Disease study. Cox models were used to examine the relationship of total cholesterol (TC), non-HDL-cholesterol (NHDL-C), triglycerides (TG), and HDL-cholesterol (HDL-C) with all-cause and cardiovascular disease (CVD) mortality and progression to kidney failure. RESULTS: During a mean follow-up of 10 years, there were 208 deaths, 128 deaths from CVD, and 554 subjects reached kidney failure. There was no association between tertiles of any of the lipid variables and mortality; the lowest HDL-C tertile (1.44, 1.18 to 1.78) had increased risk of kidney failure but covariate adjustment abolished this association. In analyses with lipids as continuous variables, there was a significant association with all-cause mortality for TC (hazard ratio [HR] per 10-mg/dl increase, 95% confidence intervals [CI] = 1.03, 1.0 to 1.06) that disappeared with covariate adjustment; there was no association of TG, HDL-C, and NHDL-C as continuous variables with all-cause or CVD mortality. There was a significant inverse association between HDL-C and kidney failure (HR = 0.93, CI = 0.87 to 0.99) in an unadjusted Cox model that was attenuated after adjustment for covariates (HR = 0.98 CI = 0.91 to 1.06). CONCLUSIONS: In this cohort, with predominantly nondiabetic CKDpatients, hyperlipidemia is not an independent predictor of long-term outcomes.
Authors: Arsalan N Habib; Bradley C Baird; John K Leypoldt; Alfred K Cheung; Alexander S Goldfarb-Rumyantzev Journal: Nephrol Dial Transplant Date: 2006-05-30 Impact factor: 5.992
Authors: Michael G Shlipak; Linda F Fried; Mary Cushman; Teri A Manolio; Do Peterson; Catherine Stehman-Breen; Anthony Bleyer; Anne Newman; David Siscovick; Bruce Psaty Journal: JAMA Date: 2005-04-13 Impact factor: 56.272
Authors: Sarah Lewington; Gary Whitlock; Robert Clarke; Paul Sherliker; Jonathan Emberson; Jim Halsey; Nawab Qizilbash; Richard Peto; Rory Collins Journal: Lancet Date: 2007-12-01 Impact factor: 79.321
Authors: Julio A Lamprea-Montealegre; Brad C Astor; Robin L McClelland; Ian H de Boer; Gregory L Burke; Christopher T Sibley; Daniel O'Leary; A Richey Sharrett; Moyses Szklo Journal: Clin J Am Soc Nephrol Date: 2012-08-09 Impact factor: 8.237
Authors: Sankar D Navaneethan; Jesse D Schold; Susana Arrigain; George Thomas; Stacey E Jolly; Emilio D Poggio; Martin J Schreiber; Mark J Sarnak; Joseph V Nally Journal: Nephrol Dial Transplant Date: 2012-05-02 Impact factor: 5.992
Authors: Archna Bajaj; Dawei Xie; Esteban Cedillo-Couvert; Jeanne Charleston; Jing Chen; Rajat Deo; Harold I Feldman; Alan S Go; Jiang He; Edward Horwitz; Radhakrishna Kallem; Mahboob Rahman; Matthew R Weir; Amanda H Anderson; Daniel J Rader Journal: Am J Kidney Dis Date: 2019-01-25 Impact factor: 8.860
Authors: Jeffrey M Saland; Juan C Kupferman; Christopher B Pierce; Joseph T Flynn; Mark M Mitsnefes; Bradley A Warady; Susan L Furth Journal: Clin J Am Soc Nephrol Date: 2019-11-11 Impact factor: 8.237